Measurements of serum inorganic phosphorus (phosphate or PO4) are used in the diagnosis and treatment of disorders including parathyroid gland and kidney diseases, and vitamin D status. Serum PO4 is regulated by coordinated efforts of vitamin D and parathyroid hormone, and PO4 levels are inversely proportional to Ca levels. Low PO4 may be associated with fatigue, paresthesias and muscle weakness, while elevated PO4 may be associated with hypoparathyroidism, hyperthyroidism, hypocalcemia and tetany.
Phosphorus is an essential mineral that plays a vital role in many bodily functions, including the formation of bones and teeth, energy production, and the functioning of cells and tissues. When it comes to urinalysis, the presence and levels of phosphorus can provide important information about a person's kidney function and overall health. The kidneys help regulate phosphorus levels in the blood, and when they are not functioning properly, phosphorus levels can become abnormal. Elevated phosphorus levels in the urine may indicate issues such as chronic kidney disease or hyperparathyroidism, a condition where the parathyroid glands produce too much hormone, leading to excessive phosphorus release. Conversely, low phosphorus levels might suggest malnutrition, alcohol abuse, or problems with phosphate regulation in the body. By measuring phosphorus in the urine, healthcare providers can gain insights into a patient's metabolic health, dietary intake, and the effectiveness of their kidneys in filtering and excreting waste products. This marker, therefore, plays a crucial role in diagnosing and monitoring various medical conditions, ensuring appropriate treatment and dietary adjustments are made to maintain optimal health.
indicative of one's ability to synthesize protein
Phosphorylated Tau 181 (pTau181) is a biomarker measured in cerebrospinal fluid (CSF) to assess the presence of abnormal tau protein associated with neurodegenerative diseases, particularly Alzheimer’s disease. Tau is a protein involved in stabilizing microtubules within neurons, but when abnormally phosphorylated at specific sites, such as threonine 181, it becomes dysfunctional and contributes to the formation of neurofibrillary tangles—a hallmark of Alzheimer’s pathology. Elevated pTau181 levels in CSF are strongly indicative of tau-related neurodegeneration and help distinguish Alzheimer’s disease from other types of dementia or neurodegenerative conditions. When analyzed alongside total tau and amyloid-beta (Aβ42) levels, pTau181 improves diagnostic accuracy for early Alzheimer’s, aiding in the differentiation of Alzheimer’s from other disorders like frontotemporal dementia. Elevated pTau181 levels reflect not only neuronal damage but also ongoing tau hyperphosphorylation, making it a critical tool for both diagnosis and monitoring disease progression.
the phosphorylated ester of the amino acid serine
Glycine/Serine Metabolites
Glycine/Serine Metabolites
Glycine/Serine Metabolites
Glycine/Serine Metabolites
Phosphoserine is a product of glycolysis.
Phosphoserine is a product of glycolysis.
used in plastic products
Produced under inflammatory conditions
Produced under inflammatory conditions
Produced under inflammatory conditions